185 related articles for article (PubMed ID: 37903990)
1. YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer.
Yuan S; Xi S; Weng H; Guo MM; Zhang JH; Yu ZP; Zhang H; Yu Z; Xing Z; Liu MY; Ming DJ; Sah RK; Zhou Y; Li G; Zeng T; Hong X; Li Y; Zeng XT; Hu H
Cell Death Differ; 2023 Dec; 30(12):2477-2490. PubMed ID: 37903990
[TBL] [Abstract][Full Text] [Related]
2. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA
Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900
[TBL] [Abstract][Full Text] [Related]
3. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA.
Zheng X; Wang Q; Zhou Y; Zhang D; Geng Y; Hu W; Wu C; Shi Y; Jiang J
Cancer Commun (Lond); 2022 Dec; 42(12):1347-1366. PubMed ID: 36209353
[TBL] [Abstract][Full Text] [Related]
4. FSP1 is a glutathione-independent ferroptosis suppressor.
Doll S; Freitas FP; Shah R; Aldrovandi M; da Silva MC; Ingold I; Goya Grocin A; Xavier da Silva TN; Panzilius E; Scheel CH; Mourão A; Buday K; Sato M; Wanninger J; Vignane T; Mohana V; Rehberg M; Flatley A; Schepers A; Kurz A; White D; Sauer M; Sattler M; Tate EW; Schmitz W; Schulze A; O'Donnell V; Proneth B; Popowicz GM; Pratt DA; Angeli JPF; Conrad M
Nature; 2019 Nov; 575(7784):693-698. PubMed ID: 31634899
[TBL] [Abstract][Full Text] [Related]
5. FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner.
Kim JW; Kim MJ; Han TH; Lee JY; Kim S; Kim H; Oh KJ; Kim WK; Han BS; Bae KH; Ban HS; Bae SH; Lee SC; Lee H; Lee EW
Cell Death Dis; 2023 Aug; 14(8):567. PubMed ID: 37633973
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous regulation of ferroptosis suppressor protein 1 and glutathione peroxidase 4 as a new therapeutic strategy of ferroptosis for esophageal squamous cell carcinoma.
Miyauchi W; Shishido Y; Matsumi Y; Matsunaga T; Makinoya M; Shimizu S; Miyatani K; Sakamoto T; Umekita Y; Hasegawa T; Fujiwara Y
Esophagus; 2023 Jul; 20(3):492-501. PubMed ID: 36576648
[TBL] [Abstract][Full Text] [Related]
7. FSP1: a key regulator of ferroptosis.
Li W; Liang L; Liu S; Yi H; Zhou Y
Trends Mol Med; 2023 Sep; 29(9):753-764. PubMed ID: 37357101
[TBL] [Abstract][Full Text] [Related]
8. Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis.
Wu YC; Huang CS; Hsieh MS; Huang CM; Setiawan SA; Yeh CT; Kuo KT; Liu SC
Aging (Albany NY); 2024 Jan; 16(1):627-647. PubMed ID: 38206305
[TBL] [Abstract][Full Text] [Related]
9. Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation.
Müller F; Lim JKM; Bebber CM; Seidel E; Tishina S; Dahlhaus A; Stroh J; Beck J; Yapici FI; Nakayama K; Torres Fernández L; Brägelmann J; Leprivier G; von Karstedt S
Cell Death Differ; 2023 Feb; 30(2):442-456. PubMed ID: 36443441
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib induces ferroptosis by promoting TRIM54-mediated FSP1 ubiquitination and degradation in hepatocellular carcinoma.
Liu MR; Shi C; Song QY; Kang MJ; Jiang X; Liu H; Pei DS
Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37695069
[TBL] [Abstract][Full Text] [Related]
11. Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis.
Hendricks JM; Doubravsky CE; Wehri E; Li Z; Roberts MA; Deol KK; Lange M; Lasheras-Otero I; Momper JD; Dixon SJ; Bersuker K; Schaletzky J; Olzmann JA
Cell Chem Biol; 2023 Sep; 30(9):1090-1103.e7. PubMed ID: 37178691
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.
Cheu JW; Lee D; Li Q; Goh CC; Bao MH; Yuen VW; Zhang MS; Yang C; Chan CY; Tse AP; Sit GF; Liu CX; Ng IO; Wong CM; Wong CC
Cell Mol Gastroenterol Hepatol; 2023; 16(1):133-159. PubMed ID: 36893885
[TBL] [Abstract][Full Text] [Related]
13. Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing.
Pontel LB; Bueno-Costa A; Morellato AE; Carvalho Santos J; Roué G; Esteller M
Redox Biol; 2022 Sep; 55():102408. PubMed ID: 35944469
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of CoQ shifts ferroptosis dependence from GPX4 to FSP1 in acquired radioresistance.
Lin X; Zhang Q; Li Q; Deng J; Shen S; Tang M; Ye X; Ji C; Yang Y; Chen Y; Zeng L; Zhao J; Kouwenhoven MBN; Lucero-Prisno DE; Huang J; Li Y; Zhang B; Hu J
Drug Resist Updat; 2024 Mar; 73():101032. PubMed ID: 38198846
[TBL] [Abstract][Full Text] [Related]
15. HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma.
Yuan J; Lv T; Yang J; Wu Z; Yan L; Yang J; Shi Y
Redox Biol; 2022 Dec; 58():102546. PubMed ID: 36423520
[TBL] [Abstract][Full Text] [Related]
16. BRD4 inhibitors broadly promote erastin-induced ferroptosis in different cell lines by targeting ROS and FSP1.
Fan C; Guo X; Zhang J; Zheng W; Shi C; Qin Y; Shen H; Lu Y; Fan Y; Li Y; Chen L; Mao R
Discov Oncol; 2024 Apr; 15(1):98. PubMed ID: 38565708
[TBL] [Abstract][Full Text] [Related]
17. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers.
Koppula P; Lei G; Zhang Y; Yan Y; Mao C; Kondiparthi L; Shi J; Liu X; Horbath A; Das M; Li W; Poyurovsky MV; Olszewski K; Gan B
Nat Commun; 2022 Apr; 13(1):2206. PubMed ID: 35459868
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis inhibitor alleviates sorafenib-induced cardiotoxicity by attenuating KLF11-mediated FSP1-dependent ferroptosis.
Li Y; Yan J; Sun H; Liang Y; Zhao Q; Yu S; Zhang Y
Int J Biol Sci; 2024; 20(7):2622-2639. PubMed ID: 38725840
[TBL] [Abstract][Full Text] [Related]
19. Fear stress promotes glioma progression through inhibition of ferroptosis by enhancing FSP1 stability.
Bu C; Hu S; Yu J; Li N; Gu J; Sheng Z; Yan Z; Bu X
Clin Transl Oncol; 2023 May; 25(5):1378-1388. PubMed ID: 36484954
[TBL] [Abstract][Full Text] [Related]
20. TRIM21-Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers.
Gong J; Liu Y; Wang W; He R; Xia Q; Chen L; Zhao C; Gao Y; Shi Y; Bai Y; Liao Y; Zhang Q; Zhu F; Wang M; Li X; Qin R
Adv Sci (Weinh); 2023 Oct; 10(29):e2302318. PubMed ID: 37587773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
